Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

Maximum Days for Obtaining Report for Severe Combined Immunodeficiency (SCID) Gene Panel Test

The maximum days for obtaining the report for the Severe Combined Immunodeficiency (SCID) Gene Panel test is 14 days.

What are the prerequisites for the test Severe Combined Immunodeficiency (SCID) Gene Panel

  • Patients must have a suspected or confirmed diagnosis of Severe Combined Immunodeficiency (SCID).
  • A physician's order requesting the test.
  • Patient's consent for genetic testing.
  • Family history and medical records of the patient.

What are the measure values for the test Severe Combined Immunodeficiency (SCID) Gene Panel

  • CD3 (Total T Cells) - Normal Range: 1500-2500 cells/µL
  • CD4 (T Helper Cells) - Normal Range: 500-1500 cells/µL
  • CD8 (Cytotoxic T Cells) - Normal Range: 200-1000 cells/µL
  • CD19 (B Cells) - Normal Range: 200-450 cells/µL
  • CD16/56 (Natural Killer Cells) - Normal Range: 100-500 cells/µL

What does this test Severe Combined Immunodeficiency (SCID) Gene Panel identify?

Severe Combined Immunodeficiency (SCID) Gene Panel

The Severe Combined Immunodeficiency (SCID) Gene Panel is a genetic test that identifies mutations in genes associated with SCID. SCID is a group of rare, inherited disorders characterized by a severe impairment of the immune system. Individuals with SCID are highly susceptible to severe, recurrent infections and are unable to fight off pathogens effectively.

The SCID Gene Panel specifically looks for mutations in genes such as IL2RG, ADA, RAG1, RAG2, and others that are known to be associated with different forms of SCID. Identifying these mutations can help healthcare providers make an accurate diagnosis of SCID and provide appropriate treatment and management strategies for affected individuals.

Why is this test Severe Combined Immunodeficiency (SCID) Gene Panel taken?

Severe Combined Immunodeficiency (SCID) Gene Panel Test

The Severe Combined Immunodeficiency (SCID) Gene Panel Test is taken to diagnose Severe Combined Immunodeficiency (SCID), a group of rare genetic disorders that affect the immune system. SCID is characterized by a severe deficiency in T cells, B cells, and natural killer (NK) cells, which are essential for the body's immune response against infections.

This test is recommended for individuals who have a family history of SCID or symptoms such as frequent and severe infections, failure to thrive, chronic diarrhea, and skin rashes. Early diagnosis of SCID is crucial as it can help in initiating appropriate treatment and management strategies to improve the patient's quality of life and reduce the risk of life-threatening infections.

The SCID Gene Panel Test analyzes specific genes associated with SCID to identify mutations or genetic variants that may be causing the immune deficiency. This information is used by healthcare providers to confirm a diagnosis of SCID, determine the type of SCID present, and guide personalized treatment decisions for the affected individual.

No FAQs available.

Customer Google Rating